VolitionRx Ltd. (NYSE: VNRX) Starts Presentation at LD Micro Main Event
VolitionRx Limited (NYSE: VNRX) is a multi-national life sciences company developing simple, easy to use blood-based cancer tests to accurately diagnose a range of cancers. The tests are based on the science of Nucleosomics®, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid — an indication that disease is present. Volition's products aim to help to diagnose a range of cancers quickly, simply, accurately and cost effectively. Volition's research and development activities are currently centered in Belgium, with additional offices in London, Texas and Singapore. For more information about Volition, visit Volition's website…







